Clinical Trial: Prevalence of Post-Thrombotic Syndrome in Deep-Vein Thrombosis (DVT) Patients Treated With Dabigatran

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational



Official Title: The Prevalence of Post-Thrombotic Syndrome in Deep-Vein Thrombosis (DVT) Patients Treated With Dabigatran- a Cross-Sectional Assessment of RE-COVER Study Patients

Brief Summary:

The primary objective in this cross-sectional study is to assess the prevalence of post-thrombotic syndrome (PTS) in the two treatment arms of the RE-COVER studies (warfarin versus dabigatran). PTS will be assessed by the recently developed Patient Reported Villalta (PRV) Score.

Secondary objectives: to assess in both treatment arms the

  1. Prevalence of recurrent venous thromboembolism (VTE) after the discontinuation of study treatment.
  2. Prevalence of PTS determined by the standard Villalta score.
  3. Health related Quality of Life (HRQoL).